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CYTOTOXICITY AND GENOTOXICITY INDUCED BY SILICA NANOPARTICLES 
IN HUMAN DENTAL PULP CELL CULTURE 
 
OMAR R. ALKHATTAB 
Boston University, Henry M. Goldman School of Dental Medicine, 2020 




This study was designed to evaluate the cell attachment efficiency, cell 
proliferation, cytotoxicity and genotoxicity of different sizes and doses of silica on human 
dental pulp cell culture. Human dental pulp cells (HDPCs) derived from extracted third 
molars were cultured in growth media and supplemented with two sizes of silica particles 
(70 nm – 225 nm) and (1 µm – 5 µm) in different doses: (12.5 µg/mL, 50 µg/mL, 100 
µg/mL and 1000 µg/mL) and media without silica particles as a control, for the time 
intervals of 16h, 24h, 7 and 14 days. Attachment efficiency and cell proliferation were 
measured by comparing optical density of crystal violet stained cells. Cytotoxicity was 
measured using water-soluble dye that changes its absorption spectra upon cellular 
reduction. Genotoxicity was measured using specific antibody-based detection. Cultures 
with Si-np50, Si-np100, Si--p12.5, Si-p50, Si-p100 at 16h yielded significantly higher 
attachment efficiency compared to the other doses. Cultures with Si-np50 and Si-np100 
showed increased attachment efficiency compared to cultures with their larger 
 
 v 
microparticles counterparts(P<0.05). Cultures with Si-p12.5 displayed similar 
proliferation compared to the control at day 14. Higher doses showed significant reduction 
in proliferation compared to lower doses in all sizes of Si-np and Si-p at day 14. All the 
silica nanoparticles groups showed lower proliferation when compared to their larger 
microparticles counterparts at 14 days (P<0.05). When comparing different doses in the 
cytotoxicity assay all the groups displayed cytotoxicity by day 14, except the Si-p12.5 
group. And when comparing different sizes, all the doses of Si-np showed higher levels of 
cytotoxicity when compared to Si-p at day 14 (P<0.05). Cultures with 1000 µg/mL group 
displayed significantly higher genotoxicity in both sizes when compared to lower doses at 
day 1. When comparing both sizes to each other, nanoparticles showed a higher 
genotoxicity than microparticles (p < 0.05). In conclusion, the higher doses of silica 
nanoparticles significantly decreased proliferation and increased cytotoxicity and 
genotoxicity on normal HDPCs in a dose and size dependent manner. This is the first report 
to demonstrate the effect of dose and size of silica particles on the proliferation, 
cytotoxicity and genotoxicity of normal HDPCs.   
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Chapter 1:  INTRODUCTION 
1.1 Nanotechnology  
Nanotechnology is a rapidly developing interdisciplinary field that became an 
important tool for a diverse range of applications in medical, chemical, aerospace 
engineering, electronics, sport and consumer products. The European Commission’s 
defines “nanomaterial”’ as natural, incidental, or manufactured materials containing 
particles in an unbound state, as an aggregate or as an agglomerate, and where for 50% or 
more of the particles in the number size distribution, one or more of their external 
dimensions is ranges from 1 nm to 100 nm (1–5). 
This rapid development in the field of nanotechnology enabled us to synthesize 
nanomaterials with unique physical, chemical, and biological properties due to the 
enhanced surface-to-volume ratio compared to their larger counterparts and to the quantum 
phenomena of nanoparticles (6–10). The behavior of nanoparticles is different from their 
larger counterparts due to two effects. The first is the lower stability of surface atoms 
compared to the bulk atoms because they have few neighbors, which results in unsatisfied 
bonds. The second is the quantum confinement effect in materials with delocalized 
electrons (11,12).  
Based on the structural dimensions, nanomaterials can be classified into three 
categories: 1) zero-dimensional nanostructures such as nanoparticles, 2) one-dimensional 
nanostructures such as nanorods, and 3) two-dimensional nanostructures such as thin films 





bioinert nanomaterials. The former include hydroxyapatite, bioglass and tricalcium 
phosphate, and the latter include titanium, alumina, zirconia, and vitreous carbon (15). 
1.2 Physicochemical Characteristics of Nanoparticles 
The characterization of properties and effects of nanoparticles is an important step 
in their synthesis for medical use because it will affect their behavior in biological tissues 
in regards to size. The optimal size of nanoparticles for in vivo delivery is in the range of 
10-100 nm, smaller particles (<10 nm) will be subjected to renal elimination while bigger 
ones (>200 nm) will be affected by reticulo-endothelial system (RES) sequestration(16). 
The life span and fate of nanoparticles in the circulation are determined by another factor, 
the surface characteristics, in order to inhibit the uptake by RES and avoid the interactions 
with plasma proteins. The surface of nanoparticles must ideally be hydrophilic (17). 
Nanoparticles planned to be used in actively targeting specific receptors on cells must be 
incorporated with appropriate ligands on their surface. Finally, it is important to study the 
biocompatibility of those particles on cells and tissues. 
1.2.1 Size  
The size of nanoparticles is considered one of the most important factors that 
determines their distribution in biological systems and interactions with cells. Size also 
plays an important role in the vascular extravasation and clearance from the human body, 
which is crucial during nanoparticles’ application as drug carriers. Dynamic light scattering 






DLS is a very popular, rapid technique that requires minimal sample preparation 
and can be done on small volumes. It monitors the fluctuations in the intensity of the 
scattered light with a photon detector when a laser beam is directed at the dispersion and 
relates it to the size of a hypothetical hard sphere that diffuses at the same fashion of those 
particles being measured. It then quantifies the Brownian motion of the nanoparticles in a 
dispersion and relates the translational diffusion coefficient or velocity to the size of 
nanoparticles using the Stokes-Einstein. 
Unfortunately, the results of the DLS can be distorted by the presence of the 
aggregates and that’s why it’s so essential to make sure that the sample is well dispersed. 
Another cause for data misrepresentation is the presence of multimodal particle size 
distribution. For example, when measuring a mixture of 100 nm and 20 nm, smaller 
particles’ signals were lost because the larger particles masked the scattering intensity of 
these small particles (19). 
Another factor that can affect the hydrodynamic size is the concentration of the 
dispersion, as a highly concentrated sample would present multiple scattering while an 
extra-diluted sample might not be sufficient to produce scattering(19). A number of 
researchers assessed the stability of nanoparticles in different types of media using DLS 
(20–22).  
In order to complement the particle size measurements that were obtained using 
DLS, electron microscopy can be used. Scanning electron microscope (SEM) provides 
valuable information about the particles’ sizes and shapes, including surface features and 





to the surface of the sample. The backscattered electrons, x-rays, and secondary electrons 
that result from the interactions with the sample are collected, and the samples of the SEM 
are mounted on a sample holder and should be electrically conductive or sputter coated 
with a conducive layer (13). 
Transmission electron microscope (TEM) is another method to analyze the 
nanoparticles in a higher resolution at the atomic scale to provide more information on the 
structure of the nanoparticles. It also utilizes an electron beam that interacts with the sample 
in high vacuum, but the difference here is that the transmitted electrons are detected (13). 
1.3 Silicon 
Silicon is one of the most abundant elements on earth, and it is found in connective 
and osseous tissues. It also plays a role in the early stages of bone formation, including 
stimulation of calcification in human tissues (23,24). Its absence has been linked to the 
development of many human disorders, including esophageal cancer, fibrotic lung disease, 
silicosis, and asbestosis. Silicon ions induce osteogenesis that causes higher levels of ALP 
and osteocalcin DSP, therefore leading to mineralization. 
The significance of silicon in bone development has been widely studied, silicon is 
required for cell proliferation and regulation of DNA replication, as well as increased cyclic 
AMP levels(25) . Silicon has also been shown to stimulate DNA synthesis and encourage 
growth in fibroblastic and osteoblastic cells(26,27). 
Clinical applications of bioactive silicon are widespread in the field of dentistry. These 
have been used for endosseous implants and in other periodontal procedures, including 






Elemental silicon, or silica, is commonly used in manufacturing computer chips 
and solar cells. In its elemental form, it is a lightweight silver-colored metal normally found 
bound to four oxygen atoms forming silica. This silica tetrahedron forms the basis for most 
silicate minerals through the binding of silicon to four oxygen atoms in a tetrahedron 
pyramid. But a silica tetrahedron is more than just a stable pyramid. Just as every silicon 
atom needs to engage itself in four bonds, and each oxygen atom needs two. This means 
each oxygen atom in a single silica tetrahedron is unsatisfied. None of the oxygen atoms 
in a single silica tetrahedron have more than their single bond with the central silicon. One 
alternative is for a number of silica tetrahedra to come together so that each oxygen atom 
binds with two silicon atoms(29). 
Silica nanoparticles are some of the most utilized nanomaterials in the field of 
nanotechnology. They can occur in numerous forms, including crystalline, simple 
amorphous, or mesoporous forms (30). Generally, mesoporous silica has a well-defined 
nanoporous structure and has been shown to be an effective drug carrier (31) and a nucleic 
acid delivery vehicle (32). Amorphous silica nanoparticles, on the other hand, are 
characterized by a non-crystalline structure and are currently employed in a wide range of 
industrial and biomedical applications (30). The relative ease by which as nanoparticles 
can be produced in different sizes and with different surface modifications has led to their 
widespread use in cosmetics (sunscreens), dentistry (toothpaste) and paints, as well as a 
food and animal feed additive (33). In biomedicine, silica nanoparticles are used as drug 





1.5 Silica Genotoxicity  
Genotoxicity is defined as a double strand break (DSB) in DNA that is a harmful 
lesion in mammalian cells. One of the common responses to DSB formation is 
phosphorylation of H2A histones. Genotoxic agents promote phosphorylation of histone 
variant H2AX that forms micronuclei at the site of DNA DSB. Phosphorylated H2AX aids 
in the assembly of proteins that are essential for DSB repair. An HCS DNA Damage Kit 
(Invitrogen) was used to detect and measure genotoxicity through specific antibody-based 
detection of phosphorylated H2AX in the nucleus is used for measuring DNA damage, 
which is accomplished by using pH2AX monoclonal antibody. 
The genotoxic potential of silica nanoparticles was investigated. However, the 
results are not consistent. Amorphous silica nanoparticles in two different sizes, 30 nm and 
80 nm, were genotoxic in 3T3-L1 mouse embryonic fibroblasts carrying lacZ reporter 
gene(38).  
On the contrary, no genotoxic findings have been observed after mouse fibroblasts 
cells were exposed to alumina-coated silica nanoparticles ranging in size from 20 nm to 
250 nm as measured by Comet Assay(39).  
Similarly, no significant increase in the micronucleus formation was found in 







1.6 Silica Cytotoxicity 
The ever-increasing globalization of silica nanoparticles in industrial and 
commercial application has augmented human exposure to silica nanoparticles in 
environmental and vocational settings. Evidence is mounting regarding the induction of 
cytotoxicity by silica nanoparticles. Studies using in vitro models have reported cytotoxic 
results after exposure of silica nanoparticles to different cell lineages (40).  
Numerous studies have demonstrated nanoparticles unique physical chemical 
properties, including size and surface characteristics, that ultimately amplify their potential 
to induce cytotoxicity(40). Numerous other studies have shown that amorphous silica has 
the potential to reduce the viability of many different human cell types or increase the 
reactive oxidative species concentration(41–45). Initial studies of silicon nanoparticles’ 
effect on rodent-derived cells have shown that these nanoparticles impair cell viability and 
induce proinflammatory cytokines such as interleukin-1, as well as increase the secretion 
of ROS (46–50). 
Exposure to silica nanoparticles should be reduced to avoid unwanted effects. In a 
study that compared different doses and sizes (20 nm and 80 nm) of silica nanoparticles on 
HFL-1 cells, a significant ROS release occurred. In addition, the induction of p53, Bax 
expression, inhibition of cl-2 production and activation of caspase 9 eventually resulted in 
the apoptosis of HFL-1 cells in a size-associated and dose-dependent manner, where the 
higher the concentration (from 250 mg/L to 2000 mg/L). The smaller the dimensions of 





Considering the existence of different toxicity levels between micro and nano 
scales, as demonstrated for TIO2 (52) , polystyrene nanoparticles (53), it is likely that 
nanosized silica can have a different effect than microscale sizes. This issue becomes 
important because of the increasing use of silica nanoparticles in different industries, as 
was mentioned earlier. 
Different forms of silica nanoparticles have different effects at the cellular level. 
Amorphous silica nanoparticles were found to be cytotoxic in a number of studies. In a 
study that compared 15 nm and 46 nm to A549 human lung cancer cells, silica 
nanoparticles were found cytotoxic after 48 and 72 hours of exposure to concentrations of 
10 micrograms per milliliter(44). 
1.7 Dental Pulp 
Dental pulp is a unique connective tissue of mesenchymal origin that is enclosed within a 
hard tissue (enamel, dentin, and cementum) that protects it from the external microbial-
rich environment. The pulp is a unique sensory organ that includes a variety of tissue 
elements, including ground substance, connective tissue fibers, vascular tissu e, 
        axons, and various types of cell (54–57) 
1.7.1 Morphologic Zones of the Pulp 
Pulp-dentin complex. Pulp is protected by dentin, which is produced by 
odontoblasts that play an important role in the pulp-dentin complex. These are located in 






Odontoblast layer. The odontoblast layer is located next to the predentin. It is the 
outermost layer of cells in healthy dental pulp and contains the cell bodies of odontoblasts, 
the processes of which pass through the predentin into dentin. It also contains nerve fibers 
and capillaries among the odontoblast cell bodies. 
Cell-poor zone. The presence or absence of this zone depends on the status of the 
pulp (63). It is a narrow zone located adjacent to the odontoblast layer that is free of cells 
and is crossed by nerve fibers, blood capillaries, and fibroblast cellular processes. 
Cell-rich zone. This zone contains a variety of cells, including macrophages, 
dendritic cells, undifferentiated mesenchymal stem cells, and fibroblasts, more of which 
are in this zone than in the most central part of the dental pulp. 
Pulp proper. This zone represents the central area of the dental pulp. It contains 
nerves, larger blood vessels, and loose connective tissue. Fibroblasts are the most 
prominent cells in this zone. 
1.7.2 Pulp Cells  
Odontoblasts. These are the most specialized cells in the pulp-dentin complex 
and play a major role in dentinogensis by producing a matrix of collagen fibrils, 
proteoglycans, and noncollagenous proteins. They exhibit the ultrastructural 
characteristics of protein secreting cells, the nuclei of which contain one or more 
prominent nucleoli that are rich in RNA, numerous mitochondria, a prominent golgi 
complex, and highly ordered RER. Odontoblasts secrete acid phosphatase and alkaline 
phosphatase(58), dentin sialoprotein, phosphophoryn(59),collagen (primarily type 





Pulp fibroblasts. Fibroblasts are the most abundant type of cells in the dental pulp. 
They appear to be tissue specific and can be differentiated if given the proper signal. They 
synthesize Types I and III collagen, GAGs, and proteoglycans, and play a role in 
phagocytosis that enables them to control collagen turnover. Further, they produce the 
matrix proteins of the interstitium at the ultrastructural level. Mature fibroblasts exhibit 
properties of protein secreting cells and appear stellate in shape, with a large golgi complex 
and RER. 
Macrophages. Macrophages are found adjacent to blood vessels. They are 
monocytes that move from the bloodstream to the tissues and are differentiated into many 
subpopulations. Because of their phagocytic activity and mobility, they act as scavengers 
for extravasated red blood cells, foreign bodies, and dead cells. A major subpopulation 
plays an important role in endocytosis and phagocytosis, while another subset has an 
important immune role in processing antigens and presenting them to memory T cells(65). 
Dendritic cells. Dendritic cells are identified by their cytoplasmic processes and 
the class II MHC complex on their cell surface. They occupy the periphery of the coronal 
pulp next to the predentin and move to the center after initiation of an immune 
response(66). They serve an important function in T cell-dependent immunity in antigen 
presentation. 
 Lymphocytes. The predominant T-lymphocyte in the human dental pulp is T8 
(suppressor) lymphocytes(67). 
Mast cells. Mast cells are found routinely in chronically inflamed pulp(68), and 





distributed in the connective tissue. They play an important role in inflammatory reactions, 
and their granules contain histamine, heparin, and other chemicals.  
1.7.3 The pulp interstitium and ground substance.  
The interstitium is amorphous and is considered a gel rather than a solid. It consists 
of an interstitial (extracellular) matrix and interstitial fluid, and occupies the extravascular 
and extracellular space. Its major structural component is collagen.  
Glycoproteins. These constitute the largest number of proteins in the ECM(69). 
Proteoglycans are an important subclass of glycoproteins that determine the physical 
characteristics of a tissue because they regulate the dispersion of interstitial matrix solutes, 
water, and colloids. They also control a variety of cellular interactions and provide cellular 
support (64).  
1.7.4 Connective Tissue Fibers of the Pulp   
Collagen and elastin are two types of structural proteins found in the dental pulp. 
Odontoblasts synthesize Type I collagen, and fibroblasts synthesize Types I, III, V, and 
VII, while elastin is a structural protein that is confined in the walls of the arterioles. 
1.7.5 Innervation.  
The nerve fibers enter through the radicular pulp with blood vessels and spread out 
beneath the cell-rich zone once they reach the coronal pulp. The innervation of the pulp is 
composed of autonomic or efferent neurons(70), which produce neurogenic balance in the 
microcirculation and inflammatory reactions(71), while afferent neurons process sensory 





myelinated (A fibers)(70–75).  
1.7.6 Vascular supply.  
The apical foramen is the main entrance for blood from the dental artery, which 
enters in arterioles with nerve bundles. Another entrance is via the lateral or accessory 
canals for the smaller vessels. Neuronal control dominates the blood flow(76–80).  
Arterioles access the center of the radicular pulp and disperse branches to the 
odontoblast layer(81). They diminish in size and branch out toward the dentin as they pass 
into the coronal pulp(82). Venules become larger as they reach the center of the pulp and 
usually have thin, muscular, discontinuous walls to facilitate fluids’ movement in and out 
of the vessels.  
1.7.7 Lymphatics.  
The pulpal lymphatic system plays an important role in the body’s immune defense. 
Its vasculature forms a network of vessels in the interstitium that collects filtered fluid and 
proteins and returns them through large lymphatics that leave the pulp via the apical 
foramen and lateral canals of the root(83,84).  
1.7.8 Pulp Functions 
The function of the pulp can be divided into 5 categories: 
1. Induction. Pulp serves a major function in dentin’s initiation and development, and 
after the dentin is formed, it also participates in the formation of enamel (85). 
2. Formation. The pulp’s specialized cells, the odontoblasts, which form dentin by 





ultimately to its mineralization. They also retain the ability to form dentin 
throughout life, which allows the pulp to compensate for loss in the hard tissue areas 
of the tooth that protects it. The dentin formed in this case is called secondary 
(physiologic) dentin or tertiary (pathologic) dentin(85). 
3. Nutrition. The pulp supplies nutrients that are important for dentin formation and 
thus maintain its integrity(85). 
4. Defense. Pulp is composed of cellular components that are important for initial 
recognition and processing of antigens. T cells are the primary immune cells, and 
the dendritic cells are the major antigen presenting cells. Another defense 
mechanism of the pulp tissue is evident in the formation of dentin in response to 
caries, trauma, or aging, as explained previously(85). 
5. Sensation. Pulp is a sensory organ that is sensitive to thermal changes. It registers 
different impulses as common sensation (pain) regardless of the nature of the stimuli 
(thermal, traumatic, or mechanical deformation), and the proprioceptive function of 
the pulp also limits the load of the masticatory muscles, thus protecting the teeth.  
The nerves in the pulp respond to stimuli that act on it directly or through enamel 










1.8 Regenerative Endodontics 
Regenerative endodontics can be defined as “biologically based procedures 
designed to replace damaged structures such as dentin, root structures, and cells of the pulp 
dentin complex” (86). 
Replacement of the affected or infected parts of a tooth with biocompatible 
materials has been the goal of dental treatment throughout history. In contrast, regenerative 
endodontics aims to replace those parts with biologically induced mechanisms (87). 
Like most of the developing fields, basic research in regenerative endodontics 
outperformed the translation of this scope into clinical studies and validated dental 
treatments (88). 
Two methods in regenerative endodontics have been proposed by Nakahara. The 
first approach is based on the principles of tissue engineering through the use of scaffolds, 
growth factors, and stem cells. The second approach is based on mimicking the embryonic 
tooth formation through natural development (89). A third approach is based on the 
regeneration of a functional dentin-pulp complex and its normal functions in the patient’s 







1.9 Experimental Basic Research in Regenerative Endodontics Field 
Applying tissue engineering concepts forms the basis of these regenerative 
endodontic procedures that aim to form tissues through the use of scaffolds, growth factors, 
and stem cells(86). 
To identify the key factors responsible for cellular behavior, such as attachment, 
differentiation, migration, and proliferation, a considerable number of in vitro studies were 
conducted, and the data obtained from animal studies in endodontic regeneration seem 
promising(88).  
1.9.1 Scaffolds 
An important element in tissue engineering is a physical scaffold (90,91) in which 
cells grow in a three-dimensional structure. They have to be uniquely developed to allow 
cellular proliferation, differentiation, migration, and attachment in the correct 
position(92,93) and selective binding and localization of cells (94). It must be 
biocompatible, biodegradable, provide structural integrity for new tissue formation and 
angiogenesis, diffusion of nutrients and oxygen that are essential for cellular growth and 
metabolism, regulate morphogenic signals that will guide stem cells differentiation and can 
be functionalized to enhance their function in tissue regeneration (95).   
Scaffolds can be divided into natural or synthetic. Examples of synthetic scaffolds 
include bio-ceramics (95), hydroxyapatite/tricalcium phosphate (96), titanium(97) 
polyglycolic acid (PGA), polylactic acid (PLA), polylactic-co-glycolic acid (PLGA), poly-





The second category of scaffolds are the natural scaffolds that include 
glycosaminoglycan, demineralized or native dentin matrix (101–103)(104,105), collagen 
(103,104) and fibrin. 
Platelet rich plasma (PRP) has shown promising results when used in endodontic 
regeneration. It fills most of the criteria listed for the ideal scaffold like providing a three-
dimensional fibrin matrix, being autologous, rich in growth factors, and easy to prepare 
and handle in the dental clinic(106,107). 
1.9.2 Morphogens/Growth Factors 
            Morphogens are extracellular secreted inductive signals that act as growth factors 
that trigger the differentiation of stem cells into odontoblasts.  
 Studies have shown that the pulp chamber size decreased with a fivefold increase 
of the predentin layer’s thickness in patients treated with long-term corticosteroids (108). 
Another study showed that human dental pulp cells were differentiated to odontoblast-like 
cells in patients treated with dexamethasone  (109,110), which was more evident after the 
addition of 1,25-dihydroxyvitamin D3 (109). Moreover, other studies showed the effect of 
ethylenediamine tetra-acetic acid (EDTA) in the exposure of the TGF-b1 from human 
dentin. Considerable small amounts of TGF-B1 where released after the dentin was treated 
with citric acid, mineral trioxide aggregate (MTA), sodium hypochlorite (NaOCL), and 
calcium hydroxide Ca(OH)2 (111,112). 
Finally, the causes of abrupt activation of stem cells in terms of different cellular 





injured are still unclear. The molecular mechanism that controls the releasing of 
morphogens needs to be explained for therapeutic use in regenerative endodontics.  
1.9.3 Stem Cells 
These cells can be defined as clonogenic cells responsible for normal tissue 
renewal, healing and regeneration after injuries, and capable of self-renewal and 
multilineage differentiation (113). They are characterized by being undifferentiated and the 
maintenance of their phenotype by the environment or adjacent cell until they get exposed 
to the cellular signals, maintain their differentiation potential throughout life, and self-
replicate for prolonged times (114). The difference between adult stem and progenitor cells 
is that progenitor cells retain the proliferation and differentiation property throughout life 
but lose their self-replication capacity (115). 
Stem cells that are used in the regenerative medical field are mainly pluripotent 
stem cells that include multipotent stem cells like the adult and somatic stem cells, 
embryonic stem cells (ES), and induced pluripotent stem cells (iPS)(116). ES and iPS are 
associated with a high risk of tumorigenesis because they have the pluripotent capacity to 
differentiate into many type of cells(117). Contrarily, somatic stem cells, which include 
mesenchymal stem cells (MSCs), have the ability to differentiate into several types only 
and are not considered pluripotent, which decreases the risk of tumorigenesis (118). MSCs 
are widely used in the regenerative therapy (119,120). 
The regulation of stem cell behavior is maintained by a stem cell niche 





of stem cells in the form of the number of cells providing cellular instructions to maintain, 
differentiate, recruit, self-renew, and increase the long-term regenerative magnitude 
(121,122). 
Dental pulp cells are a heterogonous population of mesenchymal cells and 
migrating neural crest cells(123). They are a group of precursor cells that have the capacity 
to differentiate into osteoblast-like or odontoblast-like cells and secrete type I collagen and 
various non-collagenous proteins like osteocalcin (OCN), alkaline phosphatase (ALP), 
bone sialoprotein (BSP), osteopontin (OPN), dentin matrix protein, and dentin sialo 
phosphoprotein, which are markers of differentiation(124).  Major changes in the 
cytoskeleton of microtubules, actin filaments, and intermediate filaments can be seen in 
the differentiation process (125)(126). 
The process of identification of differentiated odontoblasts is difficult because both 
of the osteoblasts and odontoblasts are similar in the mineralized nodules formation and in 
the expression of proteins(88). This makes cellular identification of a true odontoblast 
impossible to be concluded from one or two characteristics(88). 
 The differentiation into odontoblast-like cells has been reported in five different 
types of postnatal mesenchymal stem cells: dental pulp stem cells (DPSC)(127), stem cells 
of the apical papilla (SCAP)(128,129), stem cells of human exfoliated deciduous teeth 
(SHED)(130), dental follicle progenitor cells (DFPC)(131) and bone marrow derived 
mesenchymal stem cells (BMMSC) (132) . 
 Dental pulp mesenchymal stem cells (DPMSC) were first isolated from the pulp of 





perivascular area and the cell rich zone (133,134). They express MSC surface markers such 
as CD44, 90, 105, and 146, and they have the ability to differentiate to neural cells, 
chondrocytes, adipocytes, and osteoblasts(127,135) and have been reported to be a source 
of odontoblasts replacement(133,134) and the formation of dentin/pulp complex-like 
structures (127)  that make them ideal for regenerative endodontics (136). 
1.9.4 Delivery systems 
For the appropriate selection of a method to deliver these stem cells, scaffold and 
growth factors are considered the biggest challenges in tissue regeneration, which is needed 
to ensure that the regeneration process will happen in a way that prevents complete tissue 
calcification or cellular hypoxia. This is because almost all the cells in our body are within 
0.1 mm to 1 mm of a blood vessel to ensure adequate diffusion of oxygen and nutrients 
through clinical procedures based on regenerative endodontics(137,138). 
 Clinical studies in the last 50 years have focused on revascularization techniques 
with minor components of tissue engineering. Most of these studies are either case reports 
or case series, even though they don’t conclude with definitive evidence to support a 
treatment. Instead, they are considered higher evidence than in vitro and in vivo studies 
because they’re done on humans, and there is lack of clinical trials that integrate the full 
concept of tissue engineering. The main difference between tissue engineering and 
revascularization is that the former is based on stem cells assembly in a scaffold that is 





canal, hoping that it will activate an effect that will resemble the blood clot wound healing 
mechanism in surgeries (139). 
 The breakthrough in gaining knowledge and new techniques and materials has led 
to a significant increase in the number of published studies regarding the treatment of 
necrotic immaturely developed permanent teeth (88). Many procedures were performed to 
treat immature formed roots; for example, apexogenesis is defined as “a vital pulp therapy 
procedure performed to encourage continued physiologic development and formation of 
the root end,” which is mainly indicated in vital teeth. Another term is apexification, which 
is defined as “a method to induce a calcified barrier in a root with an open apex or the 
continued development of an incompletely formed root in teeth with necrotic pulp tissue” 
(140), which is different than revascularization, which is defined as “the restoration of 













1.10 Rationale and clinical significance for this research: 
Many materials have been proposed for the vital pulp therapy procedures, which is 
used to protect and preserve the vitality of teeth. Most commonly, calcium hydroxide and 
bioceramic materials. These materials have limitations in the clinical setting, such as 
handling, setting time, or moisture-dependent setting.  
Therefore, constant improvement of these materials is important to develop a 
material that will help to overcome these limitations. One of the main components in these 
materials is dicalcium silicate and tricalcium silicate, which consist of combination of 
silicon dioxide and calcium oxide. Some of the advantages of silica include its ability to be 
produced in different sizes and forms and its ability to allow surface modifications. 
Biocompatibility is one of the main challenges when dealing with materials in the 
nanometer range. There was evidence of cytotoxicity in different cell line cultures when 
silica presented in nanometer sizes and in higher does. This study investigated the effects 
of different sizes and doses of silica on the attachment efficiency, proliferation, 






































Chapter 2:  HYPOTHESIS 
It is hypothesized that silica particles at certain nano-levels will cause dose and size 
dependent cytotoxic or genotoxic effects on normal human dental pulp cell cultures. 
The null hypothesis (H0) was that there was no difference in the cytotoxicity and 
genotoxicity between the experimental sample group containing silica particles in different 
































Chapter 3:  OBJECTIVES OF THE STUDY 
Objective 1 
To measure the cellular attachment efficiency of normal human dental pulp cells 
cultured on plastic tissue culture plates containing culture media with various sizes and 
doses of silica particles (12.5 µg/mL, 50 µg/mL, 100 µg/mL and 1000 µg/mL) at 16 
hours and compare this to attachment efficiency of cells grown in media without particles 
(control). 
Objective 2 
 To quantify cellular proliferation rates of normal human dental pulp cells grown 
in culture media that contain the same various sizes and doses of silica particles (12.5 
µg/mL, 50 µg/mL, 100 µg/mL and 1000 µg/mL) at following time points 1, 7, and 14 
days, and compare this to the proliferation rates of normal human dental pulp cells grown 
in media without particles (control) at the same time points. 
Objective 3 
To evaluate the cytotoxicity of normal human dental pulp cells grown in culture 
media that contains the same various sizes and doses of silica particles (12.5 µg/mL, 50 
µg/mL, 100 µg/mL and 1000 µg/mL) at the following time points 1, 7, and 14 days, and 
compare this to the cytotoxicity of normal human dental pulp cells grown in media 









To evaluate the genotoxicity of normal human dental pulp cells grown in culture 
media that contain the same various sizes and concentrations of silica particles (12.5 
µg/mL, 50 µg/mL, 100 µg/mL and 1000 µg/mL) at  day 1, and compare this to the 
genotoxicity of normal human dental pulp cells grown in media without particles 


































Chapter 4: MATERIALS AND METHODS 
2.1 Materials 
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24 well tissue culture 
plates celltreat 
229123 
330 high speed bur midwest 386261 
High speed hand piece midwest HP200 
#7 bi bevel chisel Hu-friedy CC 
Surgical dental mallet 
ML.01 
Henry schein 100-5794 
EMD Millipore stericup 
sterile vacuum filter units, 
0.22 M 
EMD Millipore SCGVU02RE 
 


















































































































































































2.1.3 Table 3 : List of equipment used 
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TEM plasma coating 
 
 
















2.2 Approvals and training 
      This study was approved by the Institutional Biosafety Committee at Boston 
University (IBC #16-661). All necessary human subject training was completed through 
the Collaborative Institutional Training Initiative (CITI). Online lab training was provided 
through the Office of Research at Boston University. Exempt review (IRB# H-33173) from 
the human subjects was granted from the Institutional Review Board to use biological 




















2.3.1. Silica particles characterization 
        Silica nanoparticles and microparticles’ sizes, shapes and behaviors in different 
solutions were characterized to confirm the manufacturer’s specifications of those 
materials. To confirm the sizes, microparticles were analyzed through a scanning electron 
microscope, while nanoparticles’ size was confirmed by using a transmission electron 
microscope. The behavior of nanoparticles was studied through dynamic light scattering to 
ensure the particles’ stability against aggregation throughout the experiment. 
 
2.3.1.1 SEM imaging 
A scanning electron microscope (SEM) (Hitachi SU6600, Japan) was used to 
visualize the morphology and size of the SiO2 particles. Prior to this analysis, different 
sizes of SiO2 particles were dispersed in distilled water at a low concentration and dropped 
into copper grids and then mounted on aluminum stubs. Sputtering was accomplished with 
a thin layer of gold to finally acquire SEM images with an acceleration voltage of 5 kV at 








2.3.1.2 Transmission electron microscope 
The primary particle diameter and shape of Si-np were measured by transmission electron 
microscopy (TEM). Tecnai Osiris instrument was operated at 200 kV and aqueous 
suspensions of the nanoparticles were spread on a copper grid and allowed to air dry 
overnight.  
 
2.3.1.3 Dynamic light scattering 
 The mean particle sizes in suspension (hydrodynamic diameter) and agglomeration 
states of nanoparticles were determined using a dynamic light scattering device 
(Brookhaven Instrument Corporation, Holtsville, NY, USA) equipped with a 657-nm laser 
(15 mW) at a detection angle of 90 degrees. The nanoparticles’ suspensions were prepared 
in culture medium at 100 µg/mL concentrations and analyzed twice immediately after 
sonication (0 h) and 72 h of incubation. 
2.3.2 Growth media preparation 
Growth medium consisted of 10% fetal bovine serum (FBS, Atlanta Biologicals), 
1X Penicillin antibiotic (100 U/mL), 1X Streptomycin (100 g /mL), and Amphotericin B 








2.3.3 Cell culture preparation 
2.3.3.1. Isolation of progenitor cells from the human dental pulp 
The procedure to obtain human dental pulp cells was based on a previously 
published protocol (142) in which human dental pulp explants were obtained from freshly 
extracted third molars through the oral surgery department at Boston University School of 
Dental Medicine. Healthy patients with an age range of 20 to 35 years were screened to 
rule out the possibility of any metabolic or systemic disease or acute infections, including 
any steroid drugs that were taken in the six months preceding the surgery. Informed consent 
was obtained from the patients who met the inclusion criteria for sample collection. 
Exclusion criteria included caries, restorations, trauma, non-vital teeth or teeth associated 
with pathologic conditions. After the teeth were extracted, they were stored immediately 
in a centrifuge tube containing 1X PBS solution (Gibco) and then transported in a lid sealed 
icebox within one hour. 
First, sagittal indentation was made with a high-speed handpiece and fissure bur 
using a coolant without exposing the pulp. Then the teeth were fixed on extraction forceps 
and the handle was secured with rubber bands. Sectioning was carried out using a #7 
Chandler bi-bevel bone chisel (Hu-Friedy) and a hammer until the tooth was sectioned and 
the pulp exposed. The pulp tissue located in the pulp chamber was removed using sterile 
cotton pliers and placed in petri dishes containing sterile PBS. The samples were 
transported for tissue isolation and maintenance procedures, which were done entirely in a 
class II biological safety cabinet in order to ensure sterile conditions. Afterwards, the pulp 





surgical blade. One or two pieces of pulp tissue explants were placed in 12.5 cm2 flasks 
containing 10 mL culture media and labeled with the sample ID and date. The amount of 
culture media was modified to ensure that the whole tissues were covered. The culture 
flasks were maintained in an incubator at 37° C with 5% CO₂ and saturated humidity.  
Photo (1) is showing Steps of human dental pulp cells extraction. 
 
 
Photo 1 : Steps of human dental pulp cells extraction. 










2.3.3.2. Primary tissue culture maintenance and expansion 
The primary cell culture in the 12.5 cm2 flasks grew for about six to eight weeks 
until they reached 70%–80% confluence. Photo (2) is Displaying primary cell culture in 
12.5cm2 flask after 3 weeks. The growth medium was changed every two days in the first 
10 days followed by a media change every 72 hours. The method of media changing was 
as follows. First, the old medium was aspirated, then 3 mL of 1X PBS were added to 
wash the tissue and then it was aspirated. Second, a 10 mL growth medium was added. In 
the first 10 days, pulp pieces were kept in the flask to allow cell migration and 
attachment. Then those pieces were removed to provide more space for the cells to grow 



















The optimal time for primary cell culture expansion is when the primary culture 
reaches 70%–80% confluence after six to eight weeks. Photo (3) is displaying secondary 
cell culture 70-80% confluence. The process of media expansion is as follows. The medium 
was aspirated, followed by rinsing with 1X PBS and then aspirated. Then trypsinization 
was carried out using 1 mL of 0.05% trypsin EDTA for six to eight minutes in the 
incubator, thus allowing them to completely detach, which was confirmed using a light 
microscope. Then 10 mL of growth media were applied to block the trypsinization reaction, 
and cells in the growth media suspension were collected in 50mL sterile disposable tubes 
for centrifugation (five minutes with 1000 rpm at Room Temperature). When the cell pellet 
in the bottom of the tube was formed after centrifugation, the solution above the pellet 
containing the trypsin was carefully aspirated. Finally, cells were re-suspended in 10 mL 
fresh growth media and were then transferred in a new 225 cm2 flask containing 60 mL of 





















2.3.3.3. Secondary tissue culture maintenance and processing 
The secondary cell cultures in the 225 cm2 flasks grew for about 7 to 10 days until 
they reached 70%–80% confluence. The growth medium was changed every 72 hours. The 
total amount needed for the flask was 60 mL and the flask were washed with 10 mL warm 
PBS during every media change. 
The optimal time for secondary cell culture processing is when the secondary 
culture reaches 70%–80% confluence, which is after 7 to 10 days. The method of 
processing was as follows. The medium was aspirated, followed by rinsing with 10 mL 1X 
PBS and aspirated. Then trypsinization was carried out using 3 mL of 0.05% trypsin EDTA 
for six to eight minutes in the incubator, allowing cells to completely detach from the flask, 
which was confirmed using a light microscope. Then 30 mL of growth medium was applied 
to block the trypsinization reaction. Cells in the growth media suspension were collected 
in 50mL sterile disposable tubes for centrifugation (five minutes at 1000 rpm at room 
temperature). Consequently, a cell pellet was formed at the bottom of the tubes. The 
supernatant above the pellet was carefully aspirated and 10 mL of the fresh growth medium 
was added to resuspend the cellular pellet. Cell density was counted by using a 
hemocytometer (Reichert-Jung). The procedure for cell counting is as follows. First, a glass 
coverslip was attached to the hemocytometer and 20 µL cell suspension was added slowly 
to the edge of the hemocytometer to avoid bubbles. Cell suspension was then drawn into 
the chamber via capillary action. A light microscope with 20X magnification was used to 
count each cell numbers in the four big squares, and the resulting total cell number was 






































2.3.4 Determination of the optimal cell seeding concentration  
 
A pilot experiment was done to determine the ideal cell seeding concentration for 
normal human dental pulp cells in a 96-well plate for 14 days. This is important to ensure 
that cells do not reach their full confluence and do not eventually die before 14 days, which 
otherwise might undermine the experiment’s outcome. This was determined by testing 
different cell seeding concentrations on 96-well plates in triplicates. Light microscope was 
used daily to monitor the cells. After 1, 7, 14, days, the cells were fixed and stained by 
crystal violet dye and the absorbance was measured by a microplate reader to confirm the 
cell attachment. It was then concluded that the optimal cell seeding concentration for the 














2.3.5 Silica particles preparation 
Before starting each experiment, silica particle stock solutions for the nanoparticles 
and microparticles were made at a concentration of 1 mg/mL by dissolving the material in 
BME (Gibco, Invitrogen, NY, USA) and diluted to the working concentrations of 12.5 
g/mL, 50 g/mL, 100 g/mL, and 1000 g/mL. Suspensions of SiO2 nanoparticles were 
dispersed by a probe sonicator (Fisher Scientific, Pittsburgh, PA, USA) at 20% amplitude 
for 5 minutes, and then immediately applied to the HDPCs.  
2.3.6 Groups of materials: as shown in ( Photo 4 ) 
1. CM with Si-p1000  
2. CM with Si-p100  
3. CM with Si-p50  
4. CM with Si-p12.5  
5. CM with Si-np1000  
6. CM with Si-np100  
7. CM with Si-np50  
8. CM with Si-np12.5  




















CM with Si-p1000  
CM with Si-p100  
CM with Si-p50 
CM with Si-p12.5  
 
CM + Si-np1000  
CM + Si-np100 
CM + Si-np50  
CM +  Si-np12.5  
 






2.3.7 Attachment efficiency assay 
 According to a previously published study, attachment efficiency was calculated to 
establish a baseline (at 16 hours) on normal behavior of human dental pulp cells in second 
passage of cell culture (146). 
This experiment involved measuring the attachment efficiency of human dental 
pulp cells after seeding 800 cells per well in 96-well plates after being treated with various 
sizes and doses of silica particles in comparison to the control at 16 hours, the attached 
cells in the plates were fixed with 10% neutral buffered formalin solution for 1 hour at 
room temperature and stained with 0.2% (w/v) crystal violet dye for 1 hour at room 
temperature. Unbound stain was removed by rinsing plates thoroughly with deionized 
water until clear. The absorbance was measured in the spectrophotometer at 590 nm and 
recorded. As the absorbance of crystal violet is directly proportional to attached cell 











2.3.8 Proliferation rates with crystal violet staining assay 
 Crystal violet assay is a quick, reliable screening method to test the effect of 
different chemical compounds on cell proliferation. During cell death, adherent cells 
become detached from the well plates. This feature can be used to assess the differences in 
proliferation upon application of cytotoxic agents. The crystal violet dye stains the attached 
cell through binding with DNA. The optical density of the crystal violet dye that is absorbed 
by the monolayer of cells is quantified using a spectrophotometer. The dye is prepared by 
dissolving 0.2g of crystal violet in 100 mL deionized water, with a subsequent 
concentration of 0.2%(w/v).  
At the beginning, 800 cells were seeded in clear-wall, flat-bottom, 96-well plates 
containing 200 µL growth media for 16 hours until attachment, followed by aspiration then 
adding the culture medium or culture media with different sizes and doses of silica 
particles. Each condition was replicated four times. The growth medium, with or without 
the silica particles, were changed every 72 hours. The well plates were placed in the 
incubator at 37ºCwith 5% CO2 and saturated humidity. The cells proliferation rates were 
determined at the following time points: 1 day, 7 days, and 14 days. 
At 16h and each time point, the well plates were taken to the chemical hood, where 
the rest of the procedure was carried out. First, at each time point, culture medium was 
removed and cells were fixed with 10% neutral buffered formalin (Sigma) for one hour at 
RT. Fixation solution was then aspirated, plates were washed twice with 1x PBS. Later, 
plates were stained with 100 µL of 0.2% (w/v) crystal violet stain (Sigma Aldrich) for one 





until clear, then finally aspirated. The optical density of crystal violet dye was measured in 
the spectrophotometer (TECAN, infinite M200Pro) at a 590 nm wavelength. 
The per cell optical density (O.D.) was calculated by subtracting the O.D. of cells 
at 16 hours by the O.D. of the background of plastic plates and then dividing that number 
by the initial seeding number (considering full cell attachment at 16 hours’ time point). 
This gave us an estimation of the dye that was absorbed by a single cell (per cell) and then 
the per cell O.D. was used as a standard throughout the experiment to convert the optical 
density of different conditions to cell numbers. 
 
 
     𝑃𝑒𝑟 𝑐𝑒𝑙𝑙 𝑂. 𝐷. =
𝑂. 𝐷. 𝑐𝑒𝑙𝑙𝑠 𝑎𝑡 16 ℎ𝑜𝑢𝑟𝑠 −  𝑂. 𝐷. 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑




𝑂. 𝐷. 𝑟𝑒𝑎𝑑𝑖𝑛𝑔 𝑜𝑓 𝑒𝑎𝑐ℎ 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛 − 𝑂. 𝐷. 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑












2.3.9 Cytotoxicity Assay 
Measuring cell cytotoxicity is one of the most essential tasks for studying cell 
functions. The Abcam AB112118 kit utilizes a water-soluble dye that changes its 
absorption spectrum upon cellular reduction. The absorption ratio is directly proportional 
to the number of living cells. 
Briefly, HDPCs were seeded at the concentration of 800 cells per well in 96-well 
plates and were incubated for 16 hours until fully attachment. Then, the media was replaced 
with 200μl of fresh media containing the designated test groups. After 1, 7, and 14 days of 
incubation, the Abcam cytotoxicity kit was used in accordance with the manufacturer 
protocol. 40μl of the assay solution was added to each well, and the samples were incubated 
for one hour. Finally, a spectrophotometer was used to measure the absorbance at 570 nm 
(OD570) and 605 nm(OD605).  
The cell viability was calculated according to the following equation:  
Cell viability (%) = (RSample-Ro)/(RControl-Ro) × 100 where,  
RSample is the absorbance ratio (OD570/OD605) of samples cultured with silica 
particles. 
RControl is the absorbance ratio (OD570/OD605) for the samples cultured in normal 
culture media. 






2.3.10 Genotoxicity Assay 
 Genotoxicity is defined as a double strand break (DSB) in DNA that is a harmful 
lesion in mammalian cells. One of the common responses to DSB formation is 
phosphorylation of H2A histones. Genotoxic agents promote phosphorylation of histone 
variant H2AX that forms micronuclei at the site of DNA DSB. Phosphorylated H2AX aids 
in the assembly of proteins that are essential for DSB repair. An HCS DNA Damage Kit 
(Invitrogen) was used to detect and measure genotoxicity through specific antibody-based 
detection of phosphorylated H2AX.  Phosphorylated H2AX in the nucleus is used for 
measuring DNA damage, which is accomplished by using pH2AX monoclonal antibody.  
Briefly, HDPCs were seeded at the concentration of 800 cells per well in 96-well 
plates and were incubated for 16 hours until fully attachment. Then, the media were 
replaced with 200μl of fresh media containing the designated test groups. After 1 day of 
incubation, HCS DNA Damage Kit (Invitrogen) was used as recommended in the 
manufacturer protocol. 
The stock solutions were prepared freshly on the day of the assay. Component A 
was prepared by adding 1.8 μL of Image-iT® Dead Green viability stain to 6 mL of culture 
medium. The fixative solution was prepared by adding 1.5mL 16% aqueous 
paraformaldehyde solution to 4.5 mL PBS. The permeabilization solution was prepared by 
adding 15 μL of Triton® X-100 to 6 mL PBS. The blocking buffer was prepared by 
dissolving 0.25 g BSA in 25 mL PBS. The primary antibody solution was prepared by 





antibody/counterstain solution was prepared by adding 3μL of Alexa Fluor®555 goat anti-
mouse IgG and 1 μL of Hoechst 33342 to 6 mL blocking buffer. 
The process of labeling cells for imaging started by adding 50 μL of component A 
to each well that contained 100 μL of the tested medium, then incubated for 30 minutes at 
37º. The medium was then aspirated, after which 100 μL fixative solution was added to the 
plates and incubated at room temperature for 15 minutes. Fixative solution was once again 
aspirated, then the plates were washed once with PBS. Subsequently, permeabilization 
solution was added and incubated at room temperature for 15 minutes and then the plates 
were rinsed once with PBS. Following that, 100 μL of the blocking solution was added, 
incubated for 60 minutes at room temperature then aspirated. Next, 50 μL of the primary 
antibody solution was added and incubated for 60 minutes at room temperature. Then the 
solution in the plates was removed and rinsed three times with PBS. Finally, 50 μL of the 
secondary antibody/counterstain solution was added and incubated for 60 minutes at room 
temperature, protected from light. After final incubation, the solution was aspirated and 
then washed three times with PBS. To be prepared for imaging, the plates were added by 
100 μL PBS. 
Plates were scanned in a spectrophotometer equipped with a filter appropriate for 
TRITC. DNA damage was quantified by the increase of pH2AX signal in the TRITC 


































    
 2.4 STATISTICAL ANALYSIS 
Data are presented in means and standard deviations (SD). The means and SDs of 
human dental pulp cell attachment and proliferation at 16 hours and 1, 7, and 14 days 
were calculated. Cytotoxicity assay (viability percentage) was calculated at 1, 7, and 14 
days, and a genotoxicity assay was presented by the pH2AX mean average intensity at 24 
hours. All experiments were performed in quadruplicate(n=4). 
Statistical analysis was performed using software IBM SPSS (version 26) in One-
way variance statistical analysis with a Tukey multiple comparison post hoc test to detect 







































Chapter 5: RESULTS 
3.1 Characterization of silica particles  
3.1.1 SEM, TEM 
Photo 5 shows scanning electron microscopy (SEM) images of Silica 
microparticles with diameters in the range of 1 m- 5m, indicating that the particles are 
rounded and well-defined. The TEM analysis was performed to investigate the rounded 
shaped morphology. TEM and SEM measurements conducted on the micro and 
nanoparticles used in the study verified the size measurements provided by the suppliers 










Photo 5 : SEM images of SiO2 microparticles (1 - 5 m) dispersed in DI water were 













Photo 6 : SEM images of aggregated Si-np (70-225 nm) dispersed in DI water prior to 















Photo 7 : SEM images of SiO2 nanoparticles (70-225 nm) dispersed in DI water were 























































3.1.2 DLS  
The hydrodynamic size of silica nanoparticles was measured to reflect their 
dispersion throughout the experiments. The particles size distribution was 14 nm–70 nm 
with a mean of 32 nm at day 0 (Figure 1) and 38 nm-225 nm with a mean of 92 nm at day 
3 (Figure 2). Because of the Van der Waals force and hydrophobic reaction with 
surrounding media, silica nanoparticles had the larger hydrodynamic size in dispersion 















Figure 1 : The size distribution of the nanoparticles group, immediately after sonication 




































Figure 2 : The size distribution of the nanoparticles group, after 3 days, ranging from 38 











3.2 Attachment efficiency 
3.2.1   Attachment efficiency of normal human dental pulp cells affected by different 
doses of silica nanoparticles at 16 hours 
 
In order to examine if the addition of different doses of silica nanoparticles in a 
culture medium was affecting cell attachment, 800 normal human dental pulp cells were 
cultured in 96-well plates containing culture media supplemented with different doses of 
silica nanoparticles, ranging from 12.5 µg/mL to 1000 µg/mL, for 16 hours. The attached 
cells in the plates were fixed with 10% neutral buffered formalin solution for 1 hour at 
room temperature and stained with 0.2% (w/v) crystal violet dye for 1 hour at room 
temperature. Unbound stain was removed by rinsing plates thoroughly with deionized 
water until clear. The absorbance was measured in the spectrophotometer at 590 nm and 
the absorbance was recorded. As the absorbance of crystal violet is directly proportional to 
attached cell numbers, optical density was converted to cell numbers. 
 
It was noted that at 16 hours, when comparing different doses of silica 
nanoparticles, there was a significant increase in the attachment efficiency in the 50 µg/mL 
and 100 µg/mL doses compared to the rest of the groups, where lower concentrations 
showed higher attachment efficiency (p < 0.05). A significant decrease in the attachment 
efficiency was also noticed in the 1000 µg/mL group compared to the rest of the groups (p 








Figure 3 : Attachment efficiency of normal human dental pulp cells exposed to different 
doses of Silica Nanoparticles at 16 hours: 
 
Normal human dental pulp cells were cultured for 16 hours with media 
containing silica nanoparticles ranging 12.5 µg/mL to 1000 µg/mL.  
The control group was treated with growth media without supplemental silica 
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3.2.2 Attachment efficiency of normal human dental pulp cells affected by different 
doses of silica microparticles at 16 hours 
 
When comparing different doses of silica microparticles, there was a significant 
increase in the attachment efficiency at 12.5 µg/mL, 50 µg/mL and 100 µg/mL compared 
to the rest of the groups where the 50 µg/mL showed higher attachment efficiency (p < 
0.05). No statistically significant difference was noted between the control and the 1000 
















Figure 4 : Attachment efficiency of normal human dental pulp cells affected by different 
doses of silica microparticles at 16 hours 
Normal human dental pulp cells were cultured for 16 hours with media 
containing silica Microparticles ranging 12.5 µg/mL to 1000 µg/mL.  
The control group was treated with growth media without supplemental silica 
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3.2.3 Attachment efficiency of normal human dental pulp cells affected by different 
sizes of silica particles at 16 hours 
 
 In the smaller dose at 12.5 µg/mL, there was a significant increase in the cell 
attachment of the microparticles compared to the control and the nanoparticles group (p < 
0.05). Moving to the higher dose of 50 µg/mL, both nanoparticles and microparticles 
showed statistically significant higher cell attachments compared to the control, and the 
nanoparticles group was higher compared to microparticles (p < 0.05). The 100 µg/mL 
dose showed a similar pattern as the 50 µg/mL as both sizes were statistically significant 
compared to the control and the nanoparticles showed a higher cell attachment compared 
to microparticles (p < 0.05). In the highest dose of 1000 µg/mL, there was a significant 
decrease in the cell attachment of nanoparticles compared to the control and to the 
microparticles (p < 0.05). No significant difference was noted between the control and 















Figure 5 : Attachment efficiency of normal human dental pulp cells affected by different 
sizes of silica particles at 16 hours 
 
Normal human dental pulp cells were cultured for 16 hours with media containing 
different sizes of silica particles ranging 12.5 µg/mL to 1000 µg/mL.  
The control group was treated with growth media without supplemental silica 
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3.3.1 Proliferation of normal human dental pulp cells affected by different doses of 
silica nanoparticles at different time intervals:  
 
 In order to examine if the addition of different doses of silica nanoparticles in a 
culture medium was affecting the proliferation, 800 normal human dental pulp cells were 
cultured in 96-well plates containing plain medium for 16 hours until full cell attachment. 
Then the plain media was replaced with culture media containing different doses of silica 
nanoparticles, ranging from 12.5 µg/mL to 1000 µg/mL, for 1, 7 and 14 days. 
 
Initially, when human dental pulp cells proliferated at 24 hours (Figure 6), a 
significant increase in cell number was seen in the higher concentrations (1000 µg/mL 
and100 µg/mL) compared to the control group and to each other. The two groups that 
represented smaller doses (12.5 µg/mL and 50 µg/mL) behaved similar to the control group 








Figure 6 : Proliferation of normal human dental pulp cells affected by different doses of 
silica nanoparticles at 24 hours: 
Proliferation of normal human dental pulp cells with media containing silica 
nanoparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 24 hours. Cell 
number was calculated by using optical density measurement results dividing the constant 
number (per cell’s optical density).  
The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error bars 
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At seven days (Figure 7), no statistically significant difference was seen between 
the group containing 12.5 µg/mL and 50 µg/mL of silica nanoparticles and the control cells 
(p < 0.05). However, the two groups containing 100 µg/mL and 1000 µg/mL proliferated 
slower compared to the control group (p < 0.05).  A statistically significant difference was 
seen when comparing both doses with each other’s, which indicates that higher 














Figure 7 : Proliferation of normal human dental pulp cells affected by different doses of 
silica nanoparticles at 7 days: 
Proliferation of normal human dental pulp cells with media containing silica 
nanoparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 7 days. Cell number 
was calculated by using optical density measurement results dividing the constant number 
(per cell’s optical density).  
The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). 
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Surprisingly, on day 14, which was the last proliferation time point (Figure 8), the 
12.5 µg/mL and 50 µg/mL groups containing silica nanoparticles showed a statistically 
significant reduction in cell proliferation compared to the control (p <0.05). Interestingly, 
the 100 µg/mL and 1000 µg/mL groups had a significant loss of cell number compared to 















Figure 8 : Proliferation of normal human dental pulp cells affected by different doses of 
silica nanoparticles at 14 days: 
Proliferation of normal human dental pulp cells with media containing silica 
nanoparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 14 days. Cell number 
was calculated by using optical density measurement results dividing the constant number 
(per cell’s optical density).  
The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error bars 
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3.3.2 Proliferation of normal human dental pulp cells affected by different doses of 
silica microparticles at different time intervals: 
 
 Initially, when human dental pulp cells proliferated at 24 hours (Figure 9), a 
significant increase in the cell number was seen in the highest concentration compared to 
the rest of the groups that had smaller doses (p < 0.05). Interestingly, no statistical 
significance was seen between the three lower concentrations of silica microparticles 












Figure 9 : Proliferation of normal human dental pulp cells affected by different doses of 
silica microparticles at 24 hours: 
Proliferation of normal human dental pulp cells with media containing silica 
microparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 24 hours. Cell 
number was calculated by using optical density measurement results dividing the constant 
number (per cell’s optical density).  
The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error 
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At 7 days (Figure 10), the 12.5 µg/mL, 50 µg/mL groups containing silica micro 
particles proliferated faster than the control cells (p < 0.05), and when comparing both 
groups with each other, it was higher in the 12.5 µg/mL group. Statistically significant 
reductions in the proliferation can be noticed in the 100 µg/mL and 1000 µg/mL groups, 















Figure 10 : Proliferation of normal human dental pulp cells affected by different doses of 
silica microparticles at 7 days 
Proliferation of normal human dental pulp cells with media containing silica 
Microparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 7 days. Cell number 
was calculated by using optical density measurement results dividing the constant number 
(per cell’s optical density).  
The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). 
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Finally, at day 14 (Figure 11), the 12.5 µg/mL group had the same level of 
proliferation compared to the control (P>0.05). A statistically significance decrease in the 
proliferation was seen when comparing the 50 µg/mL group with the control (p < 0.05). 
The 100 µg/mL and 1000 µg/mL groups showed reductions in the proliferation (p < 0.05) 
compared to the control group and the other two groups. There was a dose-dependent 














Figure 11 : Proliferation of normal human dental pulp cells affected by different doses of 
silica microparticles at 14 days 
 
Proliferation of normal human dental pulp cells with media containing silica 
Microparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 14 days. Cell 
number was calculated by using optical density measurement results dividing the constant 
number (per cell’s optical density).  
The control group was treated with growth media without supplemental silica 
particles Groups with the same letters are not statistically significant (P>0.05). Error bars 
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3.3.3 Proliferation of normal human dental pulp cells affected by different sizes of 
silica particles at different time intervals: 
 
 Initially when human dental pulp cells proliferated at 24 hours (Figure 12), the 
12.5 µg/mL and 100 µg/mL groups showed higher proliferation in the microparticles 
compared to nanoparticles although it was not statistically significance (p > 0.05). 
Statistically significant differences were seen in the 1000 µg/mL group where both sizes 
proliferated faster than the control, and a higher proliferation was seen in the 











Figure 12 : Proliferation of normal human dental pulp cells affected by different sizes of 
silica particles at 24 hours: 
Proliferation of normal human dental pulp cells with media containing different 
sizes of silica particles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 24 hours. 
Cell number was calculated by using optical density measurement results dividing the 
constant number (per cell’s optical density).  
The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error 
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 At Day 7 (Figure 13), the 12.5 µg/mL group microparticles showed statistically 
significant increases in the proliferation compared to the control (p < 0.05), no statistically 
significant difference was seen when comparing control to nanoparticles (p > 0.05). 
However, in the 50 µg/mL, statistically significant difference was seen when comparing 
microparticles to nanoparticles (p < 0.05), where microparticles had higher proliferation 
compared to nanoparticles.  
In the 100 µg/mL group and 1000 µg/mL group, there was a statistically significant 
decrease in proliferation on both sizes compared to the control (p < 0.05). There was also 
a statistically significant decrease in the proliferation of nanoparticles compared to 










Figure 13 : Proliferation of normal human dental pulp cells affected by different sizes of 
silica particles at 7 days: 
 
 Proliferation of normal human dental pulp cells with media containing different 
sizes of silica particles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 7 days. 
Cell number was calculated by using optical density measurement results dividing the 
constant number (per cell’s optical density).  
The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error 
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Finally, at day 14 (Figure 14), in the 12.5 µg/mL group, higher proliferation in the 
microparticles was noted compared with nanoparticles (p < 0.05). In the 50 µg/mL, 100 
µg/mL, and 1000 µg/mL groups, there was a statistically significant decrease of 
proliferation in both microparticles and nanoparticles groups compared to in the control 
group. However, in the 100 µg/mL group and 1000 µg/mL groups, microparticles showed 
some minor proliferation compared to nanoparticles that showed significant decrease in 
proliferation, which might indicate that silica nanoparticles might limit the proliferation of 












Figure 14  : Proliferation of normal human dental pulp cells affected by different sizes of 
silica particles at 14 days: 
 
Proliferation of normal human dental pulp cells with media containing different 
sizes of silica particles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 14 days. 
Cell number was calculated by using optical density measurement results dividing the 
constant number (per cell’s optical density).  
The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error bars 
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3.4 Cytotoxicity  
  3.4.1 Cytotoxicity of normal human dental pulp cells affected by different doses of 
silica nanoparticles at different time intervals: 
 
In order to examine if the addition of different doses of silica nanoparticles in a 
culture medium was affecting the cytotoxicity, 800 normal human dental pulp cells were 
cultured in 96-well plates containing plain medium for 16 hours until full cell attachment. 
Then the plain media was replaced with culture media containing different doses of silica 
nanoparticles, ranging from 12.5 µg/mL to 1000 µg/mL, for 1, 7 and 14 days. 
Initially, when human dental pulp cells were exposed to silica Nano particles at 24 
hours (Figure 15), no statistically significant difference in the viability percentage was seen 
between all the groups and the control (p >0.05), which indicates that silica nanoparticles 







Figure 15 : Cytotoxicity of normal human dental pulp cells affected by different doses of 
silica nanoparticles at 24 hours 
Cytotoxicity of normal human dental pulp cells with media containing silica 
Nanoparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 24 hours. The cell 
viability was calculated according to the following equation:  
Cell viability (%) = (RSample-Ro)/(RControl-Ro) × 100 
 The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error 
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 At day 7 (Figure 16), the 12.5 µg/mL group containing silica nanoparticles was the 
only concentration shown not to be cytotoxic compared to the control. The three higher 
concentrations containing silica nanoparticles showed a statistically significant difference 
in the viability percentage compared to the control (p < 0.05). There was statistically 
significant reduction in the viability percentage between the two higher concentrations 
groups when compared to each other and compared to the 50m µg/mL group. This indicates 
that higher concentrations of silica nanoparticles are cytotoxic to human dental pulp cells 












Figure 16 : Cytotoxicity of normal human dental pulp cells affected by different doses of 
silica nanoparticles at 7 days 
Cytotoxicity of normal human dental pulp cells with media containing silica 
Nanoparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 7 days. The cell 
viability was calculated according to the following equation:  
Cell viability (%) = (RSample-Ro)/(RControl-Ro) × 100 
  The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error 
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 At Day 14 (Figure 17), all the groups showed statistically significant reductions in 
the viability percentage compared to the control (p < 0.05), there was a statistically 
significant difference between the lowest concentration and the three higher 
concentrations. No statistically significant difference was shown when comparing the two 















Figure 17 : Cytotoxicity of normal human dental pulp cells affected by different doses of 
silica nanoparticles at 14 days 
Cytotoxicity of normal human dental pulp cells with media containing silica 
Nanoparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 14 days. The cell 
viability was calculated according to the following equation:  
Cell viability (%) = (RSample-Ro)/(RControl-Ro) × 100 
  The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error 
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3.4.2 Cytotoxicity of normal human dental pulp cells affected by different doses of 
silica microparticles at different time intervals: 
 
 Initially, when human dental pulp cells were exposed to silica microparticles at 
Day 1 (Figure 18), no statistically significant differences in the viability percentage were 
noticed between the groups and the control, which represents plain media without 
particles. This shows that silica microparticles were not cytotoxic in each of the tested 












Figure 18 : Cytotoxicity of normal human dental pulp cells affected by different doses of 
silica microparticles at 24 hours 
Cytotoxicity of normal human dental pulp cells with media containing silica 
Microparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 24 hours. The cell 
viability was calculated according to the following equation:  
Cell viability (%) = (RSample-Ro)/(RControl-Ro) × 100 
  The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error 
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At Day 7 (Figure 19), no reduction in the viability percentage was seen in the 12.5 
µg/mL group and 50 µg/mL group compared to the control. Cytotoxicity was noted in the 
100 µg/mL group and 1000 µg/mL compared to the control and compared to the 12.5 
















Figure 19 : Cytotoxicity of normal human dental pulp cells affected by different doses of 
silica microparticles at 7 days 
Cytotoxicity of normal human dental pulp cells with media containing silica 
Microparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 7 days. The cell 
viability was calculated according to the following equation:  
Cell viability (%) = (RSample-Ro)/(RControl-Ro) × 100 
 The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error 
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Finally, on Day 14 (Figure 20), no reduction in the viability was detected when 
comparing the 12.5 µg/mL group to the control (p > 0.05). The 50 µg/mL, 100 µg/mL, and 
1000 µg/mL groups showed reductions in the viability percentage (p < 0.05), compared to 
the control group and when comparing between each other. This reduction seems to be in 
a dose-dependent manner, where the highest cytotoxicity can be seen in the 1000 µg/mL 














Figure 20 : Cytotoxicity of normal human dental pulp cells affected by different doses of 
silica microparticles at 14 days 
Cytotoxicity of normal human dental pulp cells with media containing silica 
Microparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 14 hours The cell 
viability was calculated according to the following equation:  
Cell viability (%) = (RSample-Ro)/(RControl-Ro) × 100 
 The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error 
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3.4.3 Cytotoxicity of normal human dental pulp cells affected by different sizes of 
silica particles at different time intervals : 
 
Initially, when human dental pulp cells were exposed to different sizes of silica 
micro and nanoparticles (Figure 21), no statistically significant difference in the viability 
percentage was seen compared to the control, which represented plain culture media 
without particles in all the groups. This indicates that silica particles didnot possess any 












Figure 21 : Cytotoxicity of normal human dental pulp cells affected by different sizes of 
silica particles at 24 hours 
Cytotoxicity of normal human dental pulp cells with media containing different 
sizes of silica particles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 24 hours. 
The cell viability was calculated according to the following equation:  
Cell viability (%) = (RSample-Ro)/(RControl-Ro) × 100 
 The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error 
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At Day 7 (Figure 22), there was no significant difference in the 12.5 µg/mL group 
compared to the control when both sizes were exposed to the human dental pulp cells (p > 
0.05). A statistically significant decrease in the viability percentage in the 50 µg/mL were 
where the nanoparticles showed a marked reduction compared to microparticles and the 
control. Significant size-dependent decreases in the viability percentages in the 100 µg/mL 
and 1000 µg/mL groups were where nanoparticles showed a decrease in the viability 
percentage compared to microparticles (p < 0.05), and both sizes showed statistically 
significant reductions in the viability percentage compared to the control (p < 0.05). This 
confirms that silica nanoparticles are cytotoxic when exposed to human dental pulp cells 










Figure 22 : Cytotoxicity of normal human dental pulp cells affected by different sizes of 
silica particles at 7 days 
Cytotoxicity of normal human dental pulp cells with media containing different 
sizes of silica particles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 7 days. 
The cell viability was calculated according to the following equation:  
Cell viability (%) = (RSample-Ro)/(RControl-Ro) × 100 
 The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error 
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 Finally, on Day 14 (Figure 23), statistically significant difference was noted in the 
12.5 µg/mL group were nanoparticles showed reduction in the viability compared to both 
microparticles and control (p < 0.05), no statistically significant difference was seen 
between microparticles and control (p > 0.05). However, statistically significant decreases 
in the viability percentages in the 50 µg/mL, 100 µg/mL, and 1000 µg/mL groups were 
where nanoparticles showed marked reductions in the viability compared to micro particles 
(p < 0.05). Both sizes showed statistically significant decreases in the viability percentages 
compared to the control, thus confirming the previous hypothesis that the decrease of cell 











Figure 23 : Cytotoxicity of normal human dental pulp cells affected by different sizes of 
silica particles at 14 days 
 
Cytotoxicity of normal human dental pulp cells with media containing different 
sizes of silica particles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 14 days. 
The cell viability was calculated according to the following equation:  
Cell viability (%) = (RSample-Ro)/(RControl-Ro) × 100 
 The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error 
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3.5.1 Genotoxicity of normal human dental pulp cells affected by different doses of 
silica nanoparticles at different time intervals: 
 
 In order to examine if the addition of different doses of silica nanoparticles in a 
culture medium was affecting the genotoxicity, 800 normal human dental pulp cells were 
cultured in 96-well plates containing plain medium for 16 hours until full cell attachment. 
Then the plain media was replaced with culture media containing different doses of silica 
nanoparticles, ranging from 12.5 µg/mL to 1000 µg/mL, for 24 hours. 
 
Initially, when human dental pulp cells proliferated at 24 hours (Figure 24), a 
significant increase in the genotoxicity was seen in all concentrations of silica nanoparticles 
when compared to the control (p < 0.05). A statistically significant difference was found 






Figure 24 : Genotoxicity of normal human dental pulp cells affected by different doses of 
silica nanoparticles at 24 hours: 
Genotoxicity of normal human dental pulp cells with media containing silica 
Nanoparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 24 hours.  
 The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error bars 
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3.5.2 Genotoxicity of normal human dental pulp cells affected by different doses of 
silica microparticles at different time intervals: 
 
Initially, when human dental pulp cells proliferated at 24 hours (Figure 25), a 
significant increase in the genotoxicity was seen in all concentrations of silica 
microparticles when compared to the control (p < 0.05). A statistically significant 
difference was found when comparing genotoxicity between different doses of silica 












Figure 25 Genotoxicity of normal human dental pulp cells affected by different doses of 
silica microparticles at 24 hours: 
 
Genotoxicity of normal human dental pulp cells with media containing silica 
Microparticles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 24 hours.  
 The control group was treated with growth media without supplemental silica particles. 
Groups with the same letters are not statistically significant (P>0.05). Error bars indicate 
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3.5.3 Genotoxicity of normal human dental pulp cells affected by different sizes of 
silica particles at different time intervals: 
 
 Initially, when human dental pulp cells proliferated at 24 hours (Figure 26), a 
significant increase in the genotoxicity was seen in all the doses of silica particles when 
compared to the control (p < 0.05). However, when comparing genotoxicity in different 
sizes of silica particles, silica nanoparticles showed higher levels of genotoxicity 













Figure 26 Genotoxicity of normal human dental pulp cells affected by different sizes of 
silica particles at 24 hours 
 
Genotoxicity of normal human dental pulp cells with media containing different 
sizes of silica particles ranging 12.5 µg/mL to 1000 µg/mL for a time period of 24 hours.  
 The control group was treated with growth media without supplemental silica 
particles. Groups with the same letters are not statistically significant (P>0.05). Error bars 
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Chapter 6: DISCUSSION 
The aim of the present study was to evaluate the attachment efficiency, 
proliferation, cytotoxic and genotoxic effects of a wide range of sizes and doses of silica 
particles on normal human dental pulp cell cultures. Most studies have revealed that silica 
particles possess a cytotoxic effect in different cell lines, in a dose and size dependent 
manner. The Findings in this study on normal human dental pulp cells were more clinically 
relevant compared to results from other studies, which used malignant cell lines or animal 
cells. With this advantage in clinical relevance, cell attachment, proliferation rate, 
cytotoxicity, and genotoxicity were investigated. 
The dental pulp is found in the center of the tooth and is made of living cells, 
including odontoblasts, endothelial cells, immune system cells, neurons, and the 
extracellular matrix. It consists of a neural network which protects it against harmful 
stimuli, and blood vessels that deliver nutrients and clear waste products. Dendritic cells, 
macrophages, and T- lymphocytes provide protection from microorganisms and other 
foreign antigens. Pulp cells and odontoblasts play important roles in the regeneration of 
dentin damaged by tooth wear or dental procedures, as well as acting as a protective defense 
in the removal of external stimuli by deposition of tertiary dentin on the pulp chamber. 
Acute pain and tissue ischemia occur in the presence of inflammatory agents that occur 






Human dental pulp stem cells (HDPSCs) are mesenchymal stem cells isolated from 
adult teeth that have the ability to differentiate into different cell lines like osteoblastic, 
chondrogenic, adipogenic, chondrogenic, and odontoblastic-like cells (144,145). These 
cells show immunosuppressive and immunomodulatory properties. They also secrete type 
I collagen and other noncollagenous proteins including osteopontin (OPN), osteocalcin 
(OCN), alkaline phosphatase (ALP), bone sialoprotein, dentin matrix protein 1, and dentin 
sialo phosphoprotein (146), therefore, making them a useful cell line for regenerative 
endodontics (136). 
Vital pulp therapy includes different procedures like direct pulp capping, indirect 
pulp capping, partial or full pulpotomy (147). Direct pulp capping is a technique aimed to 
preserve exposed dental pulp with a protective material and inducing hard tissue repair. 
Indirect pulp capping is indicated when no vital pulp exposure occurs. Pulpotomy is 
different from pulp capping only in that a part of the coronal pulp is removed before the 
capping material is applied (148). The materials used in the those procedures should have 
adequate biocompatibility and bioactivity to induce dental pulp stem cells activity and pulp 
tissue healing in permanent and primary teeth (149). 
Historically, Ca(OH)2 has been used as a direct pulp capping material because it 
can induce the formation of a dentinal bridge. However, many disadvantages, such as the 
presence of tunnels and defects in the dentinal bridge, poor adherence to the tooth structure, 
and degradation after etching, have been reported with the use of calcium hydroxide. 
Consequently, calcium hydroxide is not considered an ideal pulp capping material (150). 





(151). MTA produces a significantly larger frequency of dentinal bridge formation and less 
pulp irritation compared with calcium hydroxide. It has also been shown to facilitate the 
adhesion, migration, and attachment of undifferentiated cells to form a dentinal bridge 
(151). Because of its remarkable properties, MTA may represent the closest to ideal pulp 
capping material developed to date. Nevertheless, some concerns regarding MTA, 
including the potential release of hazardous substances, difficult handling, and long setting 
time have been raised (152). 
Recently, a bioceramic material, EndoSequence Root Repair Material (RRM; 
Brasseler USA, Savannah, GA), was introduced to endodontics. The main constituents of 
RRM are calcium silicates, tantalum pentoxide, zirconium oxide, and monobasic calcium 
phosphate. Calcium silicate was shown to induce cell differentiation (153), have 
osteoconductive effects (154), and reduce inflammation of human dental pulp cells 
(HDPCs) (155,156). The clinical applications of RRM are similar to MTA. RRM is seen 
as a superior clinical alternative to MTA because of the differences in nanostructure and 
easier manipulation (157,158). Moreover, compared with gray and white MTA, RRM 
showed a reduced risk of tooth discoloration (159). However, one of the drawbacks of this 
material is that the setting time has been demonstrated to be longer than compared to what 








Silica is found in the earth's crust and is widely used for many purposes. There are 
two forms of silica that essentially differ in their biological activity yet have the same 
molecular formula: crystalline and non-crystalline (amorphous) silica (161). The recent 
advances in nanotechnology enable us to produce different types nanoparticles with unique 
physical and chemical characteristics. 
Silica (SiO2) nanoparticles have extensive industrial applications and are additives 
to cosmetics, drugs, varnishes, and food. Recently, the use of SiO2 nanoparticles has been 
extended to biomedical and biotechnological fields, such as, in biomarkers for leukemia 
cell identification using optical imaging (162), biosensors for simultaneous assay of 
glucose, lactate, L-glutamate, and hypoxan thine levels in rat striatum (97), DNA delivery 
(163), drug delivery (164), enzyme immobilization (165), and cancer therapy (36). 
The increasing use of these nanoparticles in industrial and consumer products has 
given rise to concerns about their biological activity and environmental impact. It is 
therefore important to address the potential effects of nanoparticles on human health and 
environment (166). 
In regards to in vitro nanotoxicity studies, the careful and accurate characterizations 
of particle size, morphology, composition surface area, and surface chemistry are crucial. 
Recent studies have focused on the importance of accurate physicochemical 
characterization of nanoparticles before undertaking in vitro toxicity experiments. Most of 
the reported toxicity studies relied on the characteristics of the particles, although the 






 The cell attachment efficiency assay is essential because it is well known that a 
biomaterial’s surface characteristics can change cell behavior at many levels, such as 
differentiation, proliferation, and apoptosis. These are determined by cell shape and 
cytoskeletal organization directly, which in turn, affect cell/surface interaction (169)(170). 
The cellular interaction with a material surface depends on both chemistry and surface 
texture (topography) (171). These surface characteristics have been a subject of interest 
because they can alter protein absorption and regulate cell adhesion, proliferation, 
differentiation, and bony formation (172–176). The external membrane of a typical cell is 
covered by at least six different receptor systems that can be activated by interactions with 
neighboring cells, ligands in the surrounding (ECM), and signaling molecules (177). 
The definite mechanisms by which surface characteristics affect cellular attachment 
and growth are not yet known. The cell microenvironment is a tortuous array of chemical 
and topographical processes and recent studies have showed that surface profile size on the 
nanometer scale can affect protein adsorption (178–180). 
In a study that examined the effects of changing the Si/Ca ratio of a calcium silicate 
material on in vitro cell attachment, Alamar Blue was used for measuring cell attachment 
and proliferation. Si and Ca ion concentrations of the culture medium, in addition to three 
different calcium silicate materials seeded with MG63 cells, were quantified, and 
researchers found that the higher the Si content in the material, the more cells attached at 
all time points. Both proliferation and differentiation increased significantly (p < 0.05) with 





that the Si ion concentration of the culture medium increased significantly (p < 0.05) with 
increasing Si content and culture time (153). 
Another study investigated the role of integrin in the proliferation and 
differentiation of HDPCs cultured with calcium silicate (CS) cement and b-tricalcium 
phosphate (TCP) cement. Si ions were released from CS, and their concentration in DMEM 
increased and this, in turn, continued in proportion to culture time (181). 
We were surprised to notice that the cell attachment efficiency results from this 
study did not confirm the previous findings. In this study, higher attachment efficiency 
levels were seen when human dental pulp cells were exposed to nanoparticles in the 50 
µg/mL and 100 µg/mL groups compared to the control and other groups. When comparing 
both doses with each other, higher level of attachment was seen in the 50 µg/mL group 
compared to 100 µg/mL group. Significant decrease in the attachment was seen in the 1000 
µg/mL group compared to the control and other groups. 
Yet another study tested the effects of SiO2 particles on cell adhesion, fibroblasts 
were exposed to 100 mg/mL SiO2 particles for 10 hours, detached, and then allowed to 
adhere for another 8 to 24 hours. The morphologies, attachment, and spreading behavior 
of the particle-treated cells were different from the control group. The percentages of the 
24 hour attached cells decreased significantly to 80% and 57% after the cells were 
incubated with the 80 nm and 500 nm SiO2 particles, respectively. They concluded that 






Similarly, this study indicated that higher levels of cell attachment were seen in the 
nanoparticles compared to microparticles in the 50 µg/mL and 100 µg/mL groups. This is 
where larger particles caused less cell attachment compared to smaller particles. Different 
patterns were seen in the 12.5 µg/mL and 1000 µg/mL, where nanoparticles treated group 
showed less cell attachment compared to microparticles treated group. 
 The rate of cell growth is an essential indicator of overall cell health and of the 
possibility for nanoparticles to interfere with proliferative processes. The proliferation 
assay aims to detect changes in the number of cells and is considered a direct contact 
cytotoxicity method. 
In this study, we used a crystal violet assay which is a quick, reliable screening 
method to test the effects of different sizes and doses of silica particles on cell proliferation. 
During cell death, adherent cells become detached from the well plates, and this feature is 
used to assess the differences in proliferation upon the application of cytotoxic agents. The 
crystal violet dye stains the attached cells by binding with DNA.  
Another cytotoxicity assay used was the elution assay, which is the standard 
protocol of ISO 10993 for evaluating the biocompatibility of medical devices. It determines 









In the past, many groups used different cell lines to elaborate their findings. For 
example, human bronchoalveolar carcinoma-derived cells were utilized to evaluate 
cytotoxicity of SiO2 nanoparticles. Two sizes of silica nanoparticles were employed for 
that study (15 nm and 46 nm). Decreased cell viability after exposure to 15-nm or 46-nm 
SiO2 nanoparticles for 48 hours at dosage levels between 10 μg/ml and 100 μg/ml in a 
dose-dependent manner was noticed. However, the cytotoxicity of different sizes (15-nm 
and 46-nm) of silica nanoparticles were not significantly different. The 15-nm SiO2 
nanoparticles were used to assess time-dependent cytotoxicity. Cell viability decreased 
significantly as a function of both nanoparticle dosage and exposure (44).  
At day 14, the proliferation assay in this study demonstrated decreased cell number 
in a dose-dependent manner in both silica nanoparticles and microparticles. Decrease cell 
number was also observed in a size-dependent manner when comparing silica nanoparticles 
to silica microparticles in all doses.  
Similar to the findings in this study, another study investigated the cytotoxic effects 
of 20 nm and 50 nm silica nanoparticles on cultured human embryonic kidney cells 
(HEK293),  and they found that exposure to SiO2 nanoparticles at dosages between 20 
μg/ml and 100 μg/ml decreased cell viability in a dose-dependent manner(50). 
Similar findings were seen in a study when human lung fibroblasts (HFL-Is) were 
exposed to two different sizes of SiO2 nanoparticles. The effects of both size and 
concentration on cell responses were studied by analyzing the cell viability, the ratio of 
apoptosis, and the pathway of cell injury. They concluded that the size and dose-dependent 





I was significantly increased. This effect was accompanied by the release of cytochrome C 
from chondriosomes, upregulation of p53 expression, and activation of Bax and caspase 9 
for the inhibition of Bcl2. Apoptosis was induced by SiO2 nanoparticles by stimulating 
ROS release and subsequently causing the activation of the p53 pathway(51).  
At day 14, the cytotoxicity assay in this study demonstrated decreased cell viability 
in a dose-dependent manner in both silica nanoparticles and microparticles; furthermore, 
complete cell death was noted in the Sinp100 and Sinp1000 groups. Decreased cell 
viability was also observed in a size-dependent manner when comparing silica 
nanoparticles to silica microparticles in all doses.  
However, in a study that evaluated the systemic toxicity after applying 20 nm 
colloidal silica nanoparticles on rat skin for 90 days, unlike the inhalation route or GI route, 
the application of silica nanoparticles through skin did not result in any toxicity or any 
change in organs up to a dose of 2,000 mg/kg(182). 
A genotoxicity test is an ideal assessment of safety at the molecular level for 
nanomaterials. This is a very sensitive assay for DSBs based on the fact that a cellular 
response to these breaks is the phosphorylation of one of the nucleosomal histones, H2AX. 
The phosphorylated form is known as pH2AX, and the concentration of DSB is sufficient 
to form a focus that is visible by immunohistochemistry using a fluorescence-tagged 







Amorphous silica particles of different nano-sizes have been shown to cause 
genotoxic effects in a variety of in vitro assays, but the results were not consistent. For 
example, one study investigated the mechanisms of genetic and cellular toxicity induced 
by silica nanoparticles (SiNPs) to determine if such an effect is influenced by 
nanoparticles’ size, amorphous SiNPs (12 nm, 5 nm–10 nm, and 10 nm–15 nm), and 
micrometer size (SiP2 m). Mouse lung epithelial (FE1) cells were exposed to various 
concentrations (12.5, 25, 50, 100 g/mL) of SiNPs and SiP2m. Cellular viability, 
micronucleus formation, and mutation frequency were measured at different time points. 
A size-dependent increase in micronucleus formation was observed for SiNPs, which 
suggests that SiNPs induce cellular and genetic toxicity in a size-dependent manner (40).  
Similarly, our studies on normal human dental pulp revealed the same pattern of 
genotoxic effect, where nanoparticles resulted in a significant higher genotoxic effect 
compared to microparticles at 24 hours, and in a dose-dependent manner, where higher 
doses showed higher levels of genotoxicity compared to lower doses. 
Other study investigated the effects of nanoparticles in an in vivo 
comet/micronucleus combination assay and in an in vitro MN assay performed with 
human blood. Amorphous silica nanoparticles (15 nm and 55 nm) were studied. DNA 
damage in livers, lung and blood cells, and micronuclei in circulating reticulocytes were 
measured in Wistar rats. No genotoxic effects were observed (185). 
Other authors concluded that genotoxicity may be cell type-dependent and not a 





example, brain (A-172) and liver (Huh-7) cells have responded more quickly than stomach 
(MKN-1) and lung (A549) cells to SiO2 nanoparticles (186). 
            Contrary to the findings in this study, no significant genotoxicity was observed in 
testing of colloidal silica nanoparticles (4 g/mL and 40 g/mL) on 3T3-L1 fibroblasts at 
3, 6, and 24 hour incubations using the Comet assay (39). 
Genotoxicity was reported in other studies using different materials. In a study that 
evaluated the genotoxicity of silver nanoparticle hydrogel, a significant increase in the 
micronucleation frequency of HeLa cells was induced by silver nanoparticle hydrogel 
exposure at concentrations of 20, 40, and 60mg/ml (in medium), compared to the negative 
control, suggesting that silver nanoparticle hydrogel has high risk of genotoxicity (187). 
This is the first report to demonstrate the influence of size and dose of silica 
nanoparticles on the attachment efficiency, proliferation, cytotoxicity and genotoxicity of 
normal human dental pulp cells. These results will lead to a better understanding of the 






































Chapter 7: CONCLUSIONS  
 
It was concluded that smaller sizes and higher doses of silica particles significantly 
decrease the proliferation and produce cytotoxic and genotoxic effects on normal human 
dental pulp culture in a dose-dependent and size-dependent manner.  
This is the first report to demonstrate the influence of size and dose of silica 
nanoparticles on the attachment efficiency, proliferation, cytotoxicity and genotoxicity of 
normal human dental pulp cells. These results will lead to a better understanding of the 




















 Vital pulp therapy procedures, such as direct pulp capping and pulpotomy, are used 
to protect and preserve the vitality of teeth. Many materials have been proposed for this 
clinical application, most commonly, calcium hydroxide, mineral trioxide aggregate, and 
bioceramic materials. These materials have limitations in the clinical setting, such as 
handling, setting time, or moisture-dependent setting. Therefore, constant improvement of 
these materials is essential to develop a material that will help to overcome these 
limitations. One of the main components in these materials is silica in the form of dicalcium 
silicate and tricalcium silicate. Some of the advantages of silica include its ability to be 
produced in different sizes and forms and its ability to allow surface modifications. 
One of the main issues when dealing with materials in the nanometer range is 
biocompatibility. There was evidence of cytotoxicity in different cell line cultures when 
silica presented in nanometer sizes and in higher doses. This study investigated the effects 
of different sizes and doses of silica on the attachment efficiency, proliferation, 
cytotoxicity, and genotoxicity of the human dental pulp in vitro.  
The observed significant decrease in cell number and increase in cytotoxic and 
genotoxic effects in a size and dose dependent manner may aid in the understanding of the 
cellular behavior that would arise from the use of silica particles. These data can be used 
to develop better materials with better handling, better tissue healing, and long-term 







This in vitro study showed that amorphous silica nanoparticles down-regulated 
proliferation, induced cytotoxic and genotoxic effects in a size-, dose-, and time-dependent 
manner on normal human dental pulp cells. This study dealt with a narrow range of doses. 
Further in vitro studies should be conducted on a broader range of doses to evaluate their 
effects on pulp tissue cells, mechanism of cell death at a molecular level, and cell cycle 
analysis. Also, different forms of silica, like mesoporous particles, can be evaluated for 
their effects on human dental pulp, especially since they are being evaluated for their 
properties as drug carriers. 
 This study demonstrated the effects of different sizes and doses of silica on normal 
human dental pulp cells. Additional studies are required for evaluating their effect on other 
cell models like cancer cell lines in order to evaluate if they can produce an anticancer 
effect. Additionally, it can be evaluated on different bacterial cultures to test their 
antibacterial effects. Further studies are essential to determine the degradation rate of silica 
containing biomaterials to achieve the optimal in vivo concentrations of released silica for 
such silica-induced effects.   
Animal studies will also be essential to obtain the necessary data that may lead to 
future biocompatibility studies of those biomaterials in order to expand and improve the 
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